Therapy Areas: Cardiovascular
20 May 2019 - CellPoint, a biopharmaceutical company, announced on Friday that it plans to commence patient recruitment for its Phase 2b cardiovascular imaging study in patients suffering from coronar...
17 May 2019 - - US-based biotechnology company Exelixis, Inc.'s (NASDAQ: EXEL) partner, Japan-based Daiichi Sankyo Company, Ltd. has launched Minnebro (esaxerenone) tablets as a treatment for pat...
16 May 2019 - - Results from two Phase 1 clinical studies have been published showing that mRNA vaccines against H10N8 and H7N9 influenza viruses were well-tolerated and elicited robust immune respons...
15 May 2019 - Medical device development company Evolve Medtech Partners announced on Wednesday that Rob Abrams has joined the company's team.With more than 30 years of experience in biomedical d...
15 May 2019 - - US-based biopharmaceutical company Akebia Therapeutics, Inc. (NASDAQ: AKBA) has completed
full enrollment of its global Phase 3 INNO2VATE studies for vadadustat, the company said...
10 May 2019 - - US-based cardiovascular company Verve Therapeutics has been launched to discover and develop therapies that safely edit the adult human genome to permanently reduce a person's ris...
Related Headlines